This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of carfilzomib injection: A Synthesis of Findings from 11 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of carfilzomib injection: A Synthesis of Findings from 11 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Candesartan, an angiotensin II receptor blocker, has shown efficacy in treating hypertension and heart failure. 7 6 5 1 2 8 4 3 9 10 11 7 showed that candesartan significantly reduced the occurrence of the primary endpoint in heart failure patients who were intolerant to ACE inhibitors. This primary endpoint was a composite of cardiovascular death or hospitalization for heart failure. 6 demonstrated that candesartan improved endothelial function in hypertensive patients, reducing oxidative stress and inflammatory cytokines. This suggests an anti-atherosclerotic effect. 5 found that candesartan was significantly more effective than losartan in reducing blood pressure, indicating a superior blood pressure-lowering effect. 1 indicated that candesartan effectively reduced blood pressure in a dose-dependent manner with good safety and tolerability. 2 demonstrated that candesartan achieved maximum blood pressure reduction with doses of 16 mg and 32 mg once daily in hypertensive patients. 8 showed that candesartan was more effective than lisinopril alone in lowering blood pressure. 4 indicated that switching from ACE inhibitors, calcium channel blockers, or beta-blockers to candesartan was more effective and well-tolerated. 3 demonstrated that candesartan had a longer-lasting antagonist effect on the angiotensin AT1 receptor compared to losartan. 9 suggested that the effect of blood pressure-lowering treatment with candesartan may differ according to different types of acute ischemic stroke. 10 showed in a meta-analysis that candesartan had a greater blood pressure-lowering effect compared to telmisartan. 11 demonstrated that candesartan was more effective in reducing proteinuria in CKD patients compared to azilsartan. These studies suggest that candesartan is an effective treatment for hypertension and heart failure.

Benefits and Risks

Benefit Summary

Candesartan is an effective treatment for lowering blood pressure. 5 1 2 8 4 It may also improve endothelial function and reduce oxidative stress and inflammatory cytokines, suggesting anti-atherosclerotic effects. 6 Additionally, candesartan has been shown to significantly reduce the occurrence of the primary endpoint in heart failure patients intolerant to ACE inhibitors. 7

Risk Summary

Candesartan is generally safe. 1 2 8 4 However, it can cause side effects such as hypotension, hyperkalemia, and a decrease in glomerular filtration rate. 7 Candesartan should not be used in pregnant women. 7

Comparison of Studies

Commonalities of Studies

These studies indicate that candesartan is an effective treatment for hypertension. 5 1 2 8 4 The studies also indicate that candesartan is generally safe. 1 2 8 4

Differences of Studies

These studies show differing results regarding the blood pressure-lowering effects, safety, tolerability, and comparisons with other treatments of candesartan. 5 1 2 8 4 7 6 3 9 10 11 These differences can be attributed to variations in study design, participant characteristics, and evaluated endpoints.

Consistency and Contradictions of Results

Numerous studies have indicated that candesartan is effective in lowering blood pressure. 5 1 2 8 4 However, there is variability in the research findings regarding the effects, safety, and tolerability of candesartan. 5 1 2 8 4 7 6 3 9 10 11 These discrepancies can be attributed to variations in study design, participant characteristics, and evaluated endpoints.

Practical Application Notes

Candesartan is an effective treatment for lowering blood pressure. 5 1 2 8 4 However, it can cause side effects such as hypotension, hyperkalemia, and a decrease in glomerular filtration rate. 7 6 3 Therefore, it is essential to follow your doctor’s instructions when taking candesartan.

Current Research Limitations

The majority of studies on the effects of candesartan have been small and short-term. 5 1 2 8 4 7 6 3 9 10 11 Additionally, these studies have not adequately investigated the long-term effects of candesartan or its effects on specific populations.

Future Research Directions

Further research is needed on the long-term effects of candesartan and its effects on specific populations. 5 1 2 8 4 7 6 3 9 10 11 Additionally, the effects of combination therapy involving candesartan and other treatments should be investigated.

Conclusion

Candesartan is an effective treatment for lowering blood pressure. 5 1 2 8 4 However, there is a risk of side effects such as hypotension, hyperkalemia, and a decrease in glomerular filtration rate. 7 6 3 It is important to follow your doctor’s instructions when taking candesartan.


Literature analysis of 11 papers
Positive Content
10
Neutral Content
1
Negative Content
0
Article Type
10
1
0
0
11

Language : English


Language : English


Language : English


Language : German


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Author: SuehiroTakaichi, TsuruyaKazuhiko, YoshidaHisako, TsujikawaHiroaki, YamadaShunsuke, TanakaShigeru, TsuchimotoAkihiro, EriguchiMasahiro, FujisakiKiichiro, TorisuKumiko, NakanoToshiaki, KitazonoTakanari


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.